SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:hj-39962"
 

Search: onr:"swepub:oai:DiVA.org:hj-39962" > BDNF Val66Met and c...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

BDNF Val66Met and childhood adversity on response to physical exercise and internet-based cognitive behavioural therapy in depressed Swedish adults

Rahman, Md S. (author)
Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
Millischer, Vincent (author)
Karolinska Institutet,Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Zeebari, Zangin (author)
Karolinska Institutet,Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
show more...
Forsell, Yvonne (author)
Karolinska Institutet,Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
Lavebratt, Catharina (author)
Karolinska Institutet,Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
show less...
 (creator_code:org_t)
Elsevier, 2017
2017
English.
In: Journal of Psychiatric Research. - : Elsevier. - 0022-3956 .- 1879-1379. ; 93, s. 50-58
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The genetic effect of Brain-derived neurotrophic factor (BDNF) on treatment response in depression is not consistent in the literature. Childhood adversity is a known risk factor for depression which has been reported to increase depression susceptibility by interacting with BDNF genetic variation. We aimed to explore whether the BDNF variation Val66Met and childhood adversity (CA) predicted the treatment response to a 12-week intervention with physical exercise (PE) or internet-based cognitive behavioural therapy (ICBT) when compared with treatment as usual (TAU). A prospective cohort study nested within a randomised control trial was conducted using data from 547 participants with mild to moderate depression. Depression severity at baseline and follow-up was measured using the Montgomery-Åsberg Depression Rating Scale. Met allele carriers without exposure to CA and current antidepressant use showed higher treatment response to PE than Val homozygotes. There was no evidence to support that BDNF Val66Met or CA alone predicted treatment response to PE and ICBT. The Met carriers had higher serum mature BDNF level. These data suggest that Met allele carriers benefit more from PE treatment but only if they are not exposed to early adversity. 

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Psykiatri (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Psychiatry (hsv//eng)

Keyword

Childhood adversity
Cognitive therapy
Depression
Exercise
Gene-environment interactions
Neurotrophic factor
antidepressant agent
brain derived neurotrophic factor
methionine
valine
adult
allele
Article
childhood disease
cognitive behavioral therapy
cohort analysis
comparative study
controlled study
disease severity
female
follow up
genotype
homozygote
human
Internet
major clinical study
male
Montgomery Asberg Depression Rating Scale
outcome assessment
priority journal
prospective study
randomized controlled trial
Swedish citizen
treatment response
adolescent
child abuse
epidemiology
genetic polymorphism
genetics
metabolism
middle aged
nonparametric test
physiology
procedures
psychology
statistical model
Sweden
Brain-Derived Neurotrophic Factor
Cohort Studies
Humans
Logistic Models
Polymorphism
Genetic
Statistics
Nonparametric

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view